Expand IMMP Menu
IMMP MENU

IMMP Latest Press Releases

-- March 26, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP PRNewswire 10:00 AM

-- March 25, 2026 --

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP Newsfile 5:27 PM
IMMP Investor Alert: Immutep Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Trial Futility: Levi & Korsinsky PRNewswire 9:00 AM

-- March 22, 2026 --

ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP Newsfile 9:04 PM

-- March 20, 2026 --

IMMP Investors Have Opportunity to Join Immutep Limited Fraud Investigation with the Schall Law Firm Business Wire 8:00 PM

-- March 19, 2026 --

IMMP Investor News: If You Have Suffered Losses in Immutep Ltd. (NASDAQ: IMMP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Globe Newswire 3:07 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP PRNewswire 10:00 AM
IMMP Investor Alert: Immutep Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky Globe Newswire 9:00 AM
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases Globe Newswire 8:00 AM

-- March 18, 2026 --

IMMP Investor Alert: Immutep Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky PRNewswire 5:28 PM
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP PRNewswire 3:02 PM

-- March 17, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP Globe Newswire 6:14 PM
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP Business Wire 3:15 PM

-- March 16, 2026 --

Immutep Limited Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 8:03 AM

-- March 13, 2026 --

TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis Globe Newswire 8:00 AM

-- February 6, 2026 --

Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC Globe Newswire 8:00 AM

-- January 29, 2026 --

Immutep Quarterly Activities Report Q2 FY26 Globe Newswire 8:00 AM

-- December 16, 2025 --

Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace Globe Newswire 8:00 AM

-- December 8, 2025 --

Immutep and Dr. Reddy's enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa Globe Newswire 8:00 AM

-- December 2, 2025 --

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium Globe Newswire 8:00 AM

-- November 13, 2025 --

Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025 Globe Newswire 8:00 AM

-- November 3, 2025 --

Immutep Receives A$4.6 million R&D Tax Incentive from French Government Globe Newswire 8:00 AM

-- October 29, 2025 --

Immutep Quarterly Activities Report Q1 FY26 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes